Abbott (NYSE:ABT) announced today that it received FDA clearance and CE mark for its next-generation Ultreon 3.0 software.

Zeiss will present new AI-driven retinal imaging research and 4D optical coherence tomography (OCT) integration at the 2026 ARVO meeting, highlighting collaborations with Boehringer Ingelheim and Duke ...

Researchers have developed a computationally enhanced adaptive optics optical coherence tomography (AO-OCT) system capable of capturing full-thickness retinal images at single-cell resolution. This ...

Regular eye exams are important in detecting early signs of diabetic retinopathy to prevent vision loss. Since diabetic retinopathy doesn’t cause symptoms in its early stages, diagnostic testing can ...

Manassas, Virginia--(Newsfile Corp. - February 3, 2025) - Digital healthcare provider, Notal Vision, announced that the results of a pivotal study evaluating the performance of an artificial ...

Commercial Readiness and Launch Strategy Following FDA clearance, Conavi is actively preparing for U.S. commercialization. The Company expects to initiate a limited market release in select U.S.

Please provide your email address to receive an email when new articles are posted on . The device combines pericentric OCT scanning and Scheimpflug technology. The system is compatible with existing ...

Enabling high-speed swept-source OCT with advanced data acquisition Optical coherence tomography (OCT) has become an ...